Annual short term debt:
$4.10B+$1.24B(+43.22%)Summary
- As of today (September 17, 2025), TAK annual short term debt is $4.10 billion, with the most recent change of +$1.24 billion (+43.22%) on March 1, 2025.
- During the last 3 years, TAK annual short term debt has risen by +$1.98 billion (+93.06%).
- TAK annual short term debt is now -54.01% below its all-time high of $8.92 billion, reached on March 31, 2019.
Performance
TAK Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$2.57B-$1.53B(-37.36%)Summary
- As of today (September 17, 2025), TAK quarterly short term debt is $2.57 billion, with the most recent change of -$1.53 billion (-37.36%) on June 1, 2025.
- Over the past year, TAK quarterly short term debt has dropped by -$158.04 million (-5.79%).
- TAK quarterly short term debt is now -71.19% below its all-time high of $8.92 billion, reached on March 31, 2019.
Performance
TAK quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TAK Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.2% | -5.8% |
| 3 y3 years | +93.1% | +23.8% |
| 5 y5 years | -29.5% | -52.3% |
TAK Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.1% | -41.1% | +198.1% |
| 5 y | 5-year | -29.5% | +526.5% | -52.3% | +1074.9% |
| alltime | all time | -54.0% | >+9999.0% | -71.2% | >+9999.0% |
TAK Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.57B(-37.4%) |
| Mar 2025 | $4.10B(+43.2%) | $4.10B(+375.9%) |
| Dec 2024 | - | $861.97M(-80.2%) |
| Sep 2024 | - | $4.36B(+60.0%) |
| Jun 2024 | - | $2.73B(-4.8%) |
| Mar 2024 | $2.86B(-4.5%) | $2.86B(+9.0%) |
| Dec 2023 | - | $2.63B(+42.6%) |
| Sep 2023 | - | $1.84B(-36.1%) |
| Jun 2023 | - | $2.88B(-3.9%) |
| Mar 2023 | $3.00B(+41.2%) | $3.00B(+6.4%) |
| Dec 2022 | - | $2.82B(-28.2%) |
| Sep 2022 | - | $3.93B(+89.2%) |
| Jun 2022 | - | $2.07B(-2.3%) |
| Mar 2022 | $2.12B(+224.5%) | $2.12B(+99.0%) |
| Dec 2021 | - | $1.07B(-44.6%) |
| Sep 2021 | - | $1.93B(+780.7%) |
| Jun 2021 | - | $218.69M(-66.6%) |
| Mar 2021 | $654.66M(-88.7%) | $654.66M(-76.2%) |
| Dec 2020 | - | $2.76B(+5.1%) |
| Sep 2020 | - | $2.62B(-51.3%) |
| Jun 2020 | - | $5.38B(-7.5%) |
| Mar 2020 | $5.82B(-34.8%) | $5.82B(+3.3%) |
| Dec 2019 | - | $5.63B(+254.9%) |
| Sep 2019 | - | $1.59B(-67.2%) |
| Jun 2019 | - | $4.83B(-45.8%) |
| Mar 2019 | $8.92B(>+9900.0%) | $8.92B(+710.3%) |
| Dec 2018 | - | $1.10B(+3.4%) |
| Sep 2018 | - | $1.06B(+9850.3%) |
| Jun 2018 | - | $10.70M(-47.0%) |
| Mar 2018 | $20.17M(-99.6%) | $20.17M(-98.4%) |
| Dec 2017 | - | $1.24B(-0.1%) |
| Sep 2017 | - | $1.24B(-31.4%) |
| Jun 2017 | - | $1.81B(-63.1%) |
| Mar 2017 | $4.91B(+138.1%) | $4.91B(+142.8%) |
| Dec 2016 | - | $2.02B(-3.2%) |
| Sep 2016 | - | $2.09B(-0.2%) |
| Jun 2016 | - | $2.09B(+1.4%) |
| Mar 2016 | $2.06B(+139.6%) | $2.06B(+148.1%) |
| Dec 2015 | - | $831.26M(-0.4%) |
| Sep 2015 | - | $834.83M(+2.2%) |
| Jun 2015 | - | $817.01M(-5.1%) |
| Mar 2015 | $860.97M(-44.0%) | $860.97M(-43.2%) |
| Dec 2014 | - | $1.52B(+0.6%) |
| Sep 2014 | - | $1.51B(-0.4%) |
| Jun 2014 | - | $1.51B(>+9900.0%) |
| Mar 2014 | $1.54B | $11.90M(-12.0%) |
| Dec 2013 | - | $13.53M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $13.57M(-11.6%) |
| Jun 2013 | - | $15.35M(-67.8%) |
| Mar 2013 | $47.75M(-98.4%) | $47.75M(+147.1%) |
| Dec 2012 | - | $19.33M(-0.5%) |
| Sep 2012 | - | $19.42M(-99.4%) |
| Jun 2012 | - | $3.03B(+2.2%) |
| Mar 2012 | $2.96B(+6750.7%) | $2.96B(-57.9%) |
| Dec 2011 | - | $7.03B(-5.1%) |
| Sep 2011 | - | $7.41B(>+9900.0%) |
| Jun 2011 | - | $15.73M(-63.6%) |
| Mar 2011 | $43.22M(-26.7%) | $43.22M(+9.5%) |
| Dec 2010 | - | $39.47M(+10.2%) |
| Sep 2010 | - | $35.81M(+3.6%) |
| Jun 2010 | - | $34.56M(-41.4%) |
| Mar 2010 | $58.93M(+7.5%) | $58.93M(+68.0%) |
| Dec 2009 | - | $35.07M(+1.3%) |
| Sep 2009 | - | $34.63M(-1.5%) |
| Jun 2009 | - | $35.17M(+8.1%) |
| Mar 2009 | $54.80M(+62.3%) | $32.54M(-20.3%) |
| Dec 2008 | - | $40.81M(+48.9%) |
| Sep 2008 | - | $27.41M(-31.6%) |
| Jun 2008 | - | $40.05M(+18.6%) |
| Mar 2008 | $33.77M(-19.6%) | - |
| Mar 2008 | - | $33.77M(-21.4%) |
| Sep 2007 | - | $42.97M(+2.3%) |
| Mar 2007 | $42.02M(-9.0%) | - |
| Mar 2007 | - | $42.02M(-4.4%) |
| Sep 2006 | - | $43.97M(-4.7%) |
| Mar 2006 | $46.16M(-40.5%) | - |
| Mar 2006 | - | $46.16M(-28.8%) |
| Sep 2005 | - | $64.83M(-16.5%) |
| Mar 2005 | $77.61M(+16.4%) | - |
| Mar 2005 | - | $77.61M(+15.3%) |
| Sep 2004 | - | $67.33M |
| Mar 2004 | $66.69M(+68.2%) | - |
| Mar 2003 | $39.64M(-11.6%) | - |
| Mar 2002 | $44.86M(-40.0%) | - |
| Mar 2001 | $74.80M(-51.4%) | - |
| Mar 2000 | $153.94M(+66.0%) | - |
| Mar 1999 | $92.71M(-63.1%) | - |
| Mar 1998 | $251.08M(+122.5%) | - |
| Mar 1997 | $112.86M(-8.1%) | - |
| Mar 1996 | $122.79M(-8.0%) | - |
| Mar 1995 | $133.53M(+40.7%) | - |
| Mar 1994 | $94.89M(-21.5%) | - |
| Mar 1993 | $120.85M(+50.4%) | - |
| Mar 1992 | $80.33M(-2.7%) | - |
| Mar 1991 | $82.57M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual short term debt?
- What is the all time high annual short term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual short term debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly short term debt?
- What is the all time high quarterly short term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly short term debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual short term debt?
The current annual short term debt of TAK is $4.10B
What is the all time high annual short term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual short term debt is $8.92B
What is Takeda Pharmaceutical Company Limited annual short term debt year-on-year change?
Over the past year, TAK annual short term debt has changed by +$1.24B (+43.22%)
What is Takeda Pharmaceutical Company Limited quarterly short term debt?
The current quarterly short term debt of TAK is $2.57B
What is the all time high quarterly short term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly short term debt is $8.92B
What is Takeda Pharmaceutical Company Limited quarterly short term debt year-on-year change?
Over the past year, TAK quarterly short term debt has changed by -$158.04M (-5.79%)